This course provides newcomers a detailed and through introduction of FDA regulations in the field of medical device safety. The course includes a comprehensive review of the requirements, current compliance approaches for professionals in the reserach and post-marketing areas, and opportunities to discuss the challenges facing thse reporting and managing adverse events in the medical device industry.
- Describe current considerations in reporting adverse events in clinical trials: terminology, consent, device-related versus procedural complication, and follow-up
- Differentiate between terminology related to Adverse Events and Devices
- Define the objectives of documenting Adverse Events in both investigational and marketed devices
- Describe the reporting requirements for investigational and markete devices
- Summarize the considerations required for Adverse Event reporting combination products and in-vitro diagnostics
- Discuss the IRB's role in Adverse Event reporting
- Clinical Trial Personnel (Monitors, Managers, Research Coordinators, Support Staff) responsible for: 1) collecting, reviewinf, and reporting adverse events occuring in clinical trials of new and marketed products; and 2) ensuring adverse event reporting compliance at the investigator site
- Quality Personnel involved in the investigation of adverse event reports
- Regulatory Affairs Personnel responsible for submitting safety reports to FDA and other health authorities
- Medical Afairs Personnel responsible for safety-releated decisions regarding product labeling, regulatory interactions, or customer communication
Douglas Albrecht, B.S.N..C.C.R.A.
Click here for complete trainer biographies
2 hours; 1:00 - 3:00 p.m. Eastern
May 4, 2010
Hold this course at your company!
For more information, contact Naila Ganatra at (215) 413-2471